Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
申请人:Wagner Holger
公开号:US20110021550A1
公开(公告)日:2011-01-27
Compounds of formula (I) wherein the groups R1 to R8 have the meanings indicated in the description, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof have valuable pharmacological properties, which make them useful for the treatment of cardiovascular and related disorders.
式(I)的化合物,其中R1至R8的基团具有说明书中所示的含义,其互变异构体、立体异构体、混合物和盐具有有价值的药理特性,使它们可用于治疗心血管和相关疾病。